Prostate Cancer Patient-Derived Organoids (PDOs) as Functional Avatars for Antisense Oligonucleotide (ASO)-Based Personalized Therapy.
- DOI
- 10.1002/adhm.202505251
- Published
- 2026 Nov
- Container
- Advanced healthcare materials
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/adhm.202505251,
title = {Prostate Cancer Patient-Derived Organoids (PDOs) as Functional Avatars for Antisense Oligonucleotide (ASO)-Based Personalized Therapy.},
author = {Tran TT and Phan TTU and Baboudjian M and Duong QH and Sousa I and Le TT and Baylot V and Giusiano S and Daniel L and Brige P and Guillet B and Bastide C and Garrido C and Taïeb D and Le TK and Rocchi P},
year = {2026},
journal = {Advanced healthcare materials},
doi = {10.1002/adhm.202505251},
url = {https://doi.org/10.1002/adhm.202505251}
}RIS
TY - JOUR TI - Prostate Cancer Patient-Derived Organoids (PDOs) as Functional Avatars for Antisense Oligonucleotide (ASO)-Based Personalized Therapy. AU - Tran TT AU - Phan TTU AU - Baboudjian M AU - Duong QH AU - Sousa I AU - Le TT AU - Baylot V AU - Giusiano S AU - Daniel L AU - Brige P AU - Guillet B AU - Bastide C AU - Garrido C AU - Taïeb D AU - Le TK AU - Rocchi P PY - 2026 JO - Advanced healthcare materials DO - 10.1002/adhm.202505251 UR - https://doi.org/10.1002/adhm.202505251 ER -
APA
TT, T., TTU, P., M, B., QH, D., I, S., TT, L., V, B., S, G., L, D., P, B., B, G., C, B., C, G., D, T., TK, L., & P, R. (2026). Prostate Cancer Patient-Derived Organoids (PDOs) as Functional Avatars for Antisense Oligonucleotide (ASO)-Based Personalized Therapy.. Advanced healthcare materials. https://doi.org/10.1002/adhm.202505251
Source records
- pubmed · retrieved 2026-11-11T00:39:25.121Z